Skip to main content

Table 2 Savings if the treatment had been carried out in the 2 years of the study

From: Costs and benefits of bevacizumab vial sharing for the treatment of retinal diseases

   1631 BEVACIZUMAB VIAL SHARING COST DIFFERENCE
1631 Bevacizumab PMVG BRL$2,106,991.04 USD$543,808.02 BRL$33,109.30 USD$8545.43 BRL$2,073,881.74 USD$535,264.35
1631 Ranibizumab PMVG BRL$3,550,230.32 USD$916,295.80 BRL$33,109.30 USD$8545.43 BRL$3,517,121,02 USD$907,761.26
1631 Aflibercept PMVG BRL$4,848,685.73 USD$1,251,433.68 BRL$33,109.30 USD$8545.43 BRL$4,815,576.43 USD$1,242,889.77